The occurrence and development of diabetic nephropathy (DN) are closely related to gut microbiota. Paecilomyces cicadae is a medicinal and edible fungus. Radix astragali is a therapeutic material for unifying Chinese Qi. They can delay the occurrence and development of kidney disease. In recent years, solid-state fermentation of edible fungi and traditional Chinese medicine has become a hot issue.
Hypothesis/Gap Statement. We assumed that solid-state fermentation products of R. astragali and Paecilomyces cicadidae (RPF) could ameliorate diabetic nephropathy and modulate gut microbiota composition.
We aimed to study the function and mechanism of the RPF for ameliorating DN in mice.
We investigated the effect of the potential roles of RPF in DN mice and interaction between DN and gut microbiota using animal experiments and gut microbiota measurements.
We found that RPF dramatically reduced urine protein, serum creatinine and blood urea nitrogen in DN mice. Furthermore, RPF ameliorated the physiological condition of DN mice by regulating the abundance of intestinal microbiota such as Ruminococcaceae_UCG-014, Allobaculum, Unclassified_f__Lachnospiraceae Alloprevotella and Bacteroides.
RPF can ameliorate diabetic nephropathy and modulate gut microbiota composition.
CaniPD, DelzenneNM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des2009; 15:1546–1558 [View Article] [PubMed]
YangT, RichardsEM, PepineCJ, RaizadaMK. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol2018; 14:442–456 [View Article] [PubMed]
VaziriND. Effect of synbiotic therapy on gut-derived uremic toxins and the intestinal microbiome in patients with CKD. Clin J Am Soc Nephrol2016; 11:199–201 [View Article] [PubMed]
MishimaE, FukudaS, MukawaC, YuriA, KanemitsuY et al. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int2017; 92:634–645 [View Article] [PubMed]
ChavesLD, McSkimmingDI, BryniarskiMA, HonanAM, AbyadS et al. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. Am J Physiol Renal Physiol2018; 315:F487–F502 [View Article] [PubMed]
FuJ, WangZ, HuangL, ZhengS, WangD et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res2014; 28:1275–1283 [View Article] [PubMed]
AiP, YongG, DingkunG, QiuyuZ, KaiyuanZ et al. Aqueous extract of Astragali Radix induces human natriuresis through enhancement of renal response to atrial natriuretic peptide. J Ethnopharmacol2008; 116:413–421 [View Article] [PubMed]
CaoT, XuR, XuY, LiuY, QiD et al. The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro. Int Urol Nephrol2019; 51:1883–1892 [View Article] [PubMed]
LiL, WangL, FanW, JiangY, ZhangC et al. The Application of Fermentation Technology in Traditional Chinese Medicine: A Review. Am J Chin Med2020; 48:899–921 [View Article] [PubMed]
ZhaoCY, YangF, QUQS, LIUZY, GaoPF et al. Establishment of bidirectional fermentation system of paecilomyces cicadae /astragalus membranaceus and study on its components. WCM2018; 13:3195–3198
GuoH, WangY, ZhangX, ZangY, ZhangY et al. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy. Sci Rep2017; 7:6852 [View Article] [PubMed]
AzizKMA. Correlation of urine biomarkers: microalbuminuria and spot urine protein among diabetic patients. application of spot urine protein in diabetic kidney disease, nephropathy, proteinuria estimation, diagnosing and monitoring. Recent Pat Endocr Metab Immune Drug Discov2015; 9:121–133 [View Article] [PubMed]
LiM, WangW, XueJ, GuY, LinS. Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. J Ethnopharmacol2011; 133:412–419 [View Article] [PubMed]
GohS-Y, JasikM, CooperME. Agents in development for the treatment of diabetic nephropathy. Expert Opin Emerg Drugs2008; 13:447–463 [View Article] [PubMed]
LiX-W, ChenH-P, HeY-Y, ChenW-L, ChenJ-W et al. Effects of rich-polyphenols extract of Dendrobium loddigesii on anti-diabetic, anti-inflammatory, anti-oxidant, and gut microbiota modulation in db/db Mice. Molecules2018; 23:3245 [View Article]
XuK-Y, XiaG-H, LuJ-Q, ChenM-X, ZhenX et al. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep2017; 7:1445 [View Article] [PubMed]
ChenR, WangJ, ZhanR, ZhangL, WangX. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill. J Ethnopharmacol2019; 244:112139 [View Article] [PubMed]
TurnbaughPJ, HamadyM, YatsunenkoT, CantarelBL, DuncanA et al. A core gut microbiome in obese and lean twins. Nature2009; 457:480–484 [View Article] [PubMed]
WuR, ZhaoD, AnR, WangZ, LiY et al. Linggui zhugan formula improves glucose and lipid levels and alters gut microbiota in high-fat diet-induced diabetic mice. Front Physiol2019; 10:918 [View Article] [PubMed]
BrugmanS, KlatterFA, VisserJTJ, Wildeboer-VelooACM, HarmsenHJM et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia2006; 49:2105–2108 [View Article] [PubMed]
LarsenN, VogensenFK, van den BergFWJ, NielsenDS, AndreasenAS et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE2010; 5:e9085 [View Article] [PubMed]
MurugesanS, NirmalkarK, Hoyo-VadilloC, García-EspitiaM, Ramírez-SánchezD et al. Gut microbiome production of short-chain fatty acids and obesity in children. Eur J Clin Microbiol Infect Dis2018; 37:621–625 [View Article] [PubMed]
MeehanCJ, BeikoRG. A phylogenomic view of ecological specialization in the Lachnospiraceae, A family of digestive tract-associated bacteria. Genome Biol Evol2014; 6:703–713 [View Article] [PubMed]
MenniC, LinC, CeceljaM, ManginoM, Matey-HernandezML et al. Gut microbial diversity is associated with lower arterial stiffness in women. Eur Heart J2018; 39:2390–2397 [View Article] [PubMed]
TangWHW, WangZ, KennedyDJ, WuY, BuffaJA et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res2015; 116:448–455 [View Article] [PubMed]
SaleemT, DahpyM, EzzatG, AbdelrahmanG, Abdel-AzizE et al. The profile of plasma free amino acids in type 2 diabetes mellitus with insulin resistance: association with microalbuminuria and macroalbuminuria. Appl Biochem Biotechnol2019; 188:854–867 [View Article]
CoxLM, YamanishiS, SohnJ, AlekseyenkoAV, LeungJM et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell2014; 158:705–721 [View Article] [PubMed]
KameyamaK, ItohK. Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microbes Environ2014; 29:427–430 [View Article] [PubMed]